Page last updated: 2024-08-22

sizofiran and Lymphoma

sizofiran has been researched along with Lymphoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, J1
Hashimoto, J; Kakuta, H; Kano, Y3

Other Studies

4 other study(ies) available for sizofiran and Lymphoma

ArticleYear
[Immunotherapy of malignant lymphoma with interleukin-2 and sizofiran--a basic study on EL-4 lymphoma-transplanted mice].
    Nihon Jibiinkoka Gakkai kaiho, 1994, Volume: 97, Issue:7

    Topics: Animals; Female; Immunotherapy; Interleukin-2; Lymphoma; Mice; Mice, Inbred C57BL; Recombinant Proteins; Sizofiran; T-Lymphocytes

1994
Augmentation of antitumor effect by combined administration with interleukin-2 and sizofiran, a single glucan, on murine EL-4 lymphoma.
    Biotherapy (Dordrecht, Netherlands), 1996, Volume: 9, Issue:4

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cytotoxicity, Immunologic; Flow Cytometry; Humans; Interleukin-2; Lymphoma; Mice; Mice, Inbred C57BL; Recombinant Proteins; Sizofiran; Survival Rate

1996
Inhibitory effect of metastasis by combined administration with interleukin-2 and sizofiran, a single glucan--immunohistochemical study.
    Biotherapy (Dordrecht, Netherlands), 1996, Volume: 9, Issue:4

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Female; G(M1) Ganglioside; Immunohistochemistry; Interleukin-2; Liver; Lymphoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Recombinant Proteins; Sizofiran; Spleen

1996
Augmentation of the antitumor effect of adoptive immunotherapy by in vivo sensitization of EL-4 lymphoma and pre-treatment with sizofiran.
    Biotherapy (Dordrecht, Netherlands), 1998, Volume: 11, Issue:1

    Topics: Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Humans; Immunotherapy, Adoptive; Killer Cells, Lymphokine-Activated; Liver Neoplasms, Experimental; Lymphoma; Mice; Mice, Inbred C57BL; Mitomycin; Sizofiran; Spleen; Splenic Neoplasms

1998